ZMapp: Experimental drug to treat Ebola infected U.S. Aid Workers

August 7, 2014

A small biotech company Mapp Biopharmaceutical Inc. based in San Diego-based has provided an experimental Ebola treatment for two Americans infected with the deadly virus in Liberia. The biotechnology drug, produced with tobacco plants, appears to be working.
The company which has just nine employees released its experimental ZMapp drug, until now only tested on infected animals, for the two health workers. Kentucky BioProcessing LLC, a subsidiary of tobacco giant Reynolds American Inc. (RAI), manufactures the treatment for Mapp from tobacco plants.
As per the relatives and supporters of both these workers, their health condition is now improving.

« Previous Post Next Post »